Extractable Volume Test

The Extractable Volume Test is a compendial, physical test performed on parenteral drug products to confirm that the volume of solution that can be withdrawn from the final container meets or exceeds the labeled volume. It is a compendial final product release test for most parenteral drug products final product release test designed to simulate the clinical withdrawal of a dose, ensuring patient safety and consistent dosing.

This is a fundamental physical test that has not evolved significantly over time. The procedure is manual and designed to mimic the action of a healthcare professional. It remains the universal standard, and there are no emerging alternatives as the goal is to simulate the current, real-world process of dose withdrawal.

The principle is a direct physical measurement of the volume that can be withdrawn from a container using a standardized technique.

• Output: A quantitative, measured volume (in mL) for each container or group of containers tested.
• Interpretation: The result is a direct pass/fail determination. Acceptance criteria are defined in USP <1> and EP 2.9.17, typically requiring that the measured extractable volume from each container (or from a defined number tested) meets or exceeds the labeled volume.

• Clinically Relevant: The test directly simulates the real-world action of a healthcare professional preparing a dose.
• Simple and Direct: The principle and procedure are straightforward and easy to understand.
• Compendial: The method is clearly defined in the pharmacopeias, making it a universally accepted standard.

• Technique Dependent: The result can be highly variable if the analyst does not use a consistent and proper withdrawal technique.
• Measurement Error: Accurately reading a liquid volume in a syringe or graduated cylinder is subject to parallax and other sources of human error.
• Component Variability: Stopper design, container geometry, and syringe/needle type can influence the residual volume and therefore impact test results.

As a compendial physical test, ICH Q2(R2) validation does not apply. Instead, per USP <1226>, compendial methods must be verified to demonstrate suitability under actual laboratory conditions. The key consideration is demonstrating the suitability and consistency of the procedure as performed in your laboratory.

• Analyst Training & Qualification: This is the most critical component. Analysts must be thoroughly trained on the specific withdrawal technique and must pass a formal qualification to demonstrate that they can perform the test accurately and reproducibly.
• Component Specification: The specific size and type of syringe and needle must be clearly defined in the standard operating procedure (SOP).

Standardization of the Extractable Volume Test is defined in pharmacopeial procedures (USP <1>, EP 2.9.17, USP <697>) and relies on using consistent, controlled techniques that simulate clinical withdrawal. Critical parameters such as container orientation, needle gauge, syringe type, and withdrawal angle must be specified in the SOP to ensure reproducibility. Reference materials are not required in the same way as for analytical assays, but laboratories typically verify performance with calibrated volumetric glassware or gravimetric checks against water standards to confirm accuracy of volume measurement. Lifecycle controls include periodic analyst requalification and verification of compendial methods per USP <1226>.

mAbs, AAVs, Vaccines, Cell Therapies: This test is universal. It is performed on the final container of essentially all parenteral drug products, regardless of the modality. The principle and procedure remain the same.